Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Online Appendix for the following JACC article TITLE: Renal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions AUTHORS: Hitinder S. Gurm, MD, Simon R. Dixon, MBChB, Dean E. Smith, PhD, MPH, David Share, MD, Thomas LaLonde, MD, Adam Greenbaum, MD, Mauro Moscucci, MD, MBA, for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry APPENDIX The variables included in the final multivariate model for both CIN and NRD were age, gender; weight; baseline creatinine (mg/dL); creatinine clearance; history of hypertension, diabetes, congestive heart failure, extra-cardiac vascular disease, significant valve disease, prior PCI, prior CABG, chronic obstructive pulmonary disease; emergency PCI, Myocardial infarction within 7 days, cardiac arrest, cardiogenic shock, anemia, left ventricular ejection fraction < 50, left main stenosis > 70%, three vessel coronary disease, visible thrombus, and calcification. Supplementary Table. Baseline Characteristics of Study Patients compared with those excluded due to absence of post PCI creatinine determination Baseline Characteristics of Study Patients compared with those excluded due to absence of post PCI creatinine determination Risk Factor Study cohort Patients excluded Demographic N = 45,429 N = 9,097 p-value Age (60-69) 28.5 29.6 0.04 Age (70-79) 23.0 24.2 0.02 Age (80+) 12.4 9.7 <0.0001 Female 34.1 33.6 0.33 Current Smoking 27.5 27.0 0.37 Lean (BMI <25) 18.5 16.5 <0.0001 Obese (BMI >30) 46.2 48.6 <0.0001 Hypertension 83.6 84.9 0.001 Prior MI 34.6 36.5 0.0004 Diabetes 35.6 33.6 0.0003 Congestive heart failure 15.9 11.8 <0.0001 Extracardiac vascular disease 26.3 24.1 <0.0001 Significant valve disease 3.98 2.44 <0.0001 Gastro-intestinal bleeding 1.68 0.69 <0.0001 Atrial Fibrillation 10.5 7.8 <0.0001 Cardiac arrest 1.30 1.15 0.26 Prior PCI 44.2 51.7 <0.0001 Prior CABG 19.5 20.2 0.12 COPD 19.6 19.0 0.19 Baseline creatinine >1.5 mg/dL 10.5 5.7 < 0.0001 Anemia 28.1 20.2 <0.0001 Historical Laboratory Ejection fraction < 50% 32.0 22.4 <0.0001 Emergency PCI 15.1 4.2 <0.0001 MI (prior 7 days) 33.3 14.9 <0.0001 Acute MI (<24 hrs.) 20.1 7.1 <0.0001 Cardiac arrest 1.49 0.57 <0.0001 Cardiogenic shock 1.75 0.56 <0.0001 Ventricular Tachycardia / 1.35 0.43 <0.0001 Left main stenosis >70% 3.76 3.11 0.002 Restenotic lesion 10.3 10.0 0.37 Visible thrombus 12.8 5.1 <0.0001 Calcification 12.3 14.8 <0.0001 Chronic total inclusion 2.05 2.47 0.01 Procedural Fibrillation The characteristics of patients who were excluded from the study due to absence of missing post procedural creatinine compared with the study cohort. Supplementary Figure Legends Supplementary Figure 1. The incidence of CIN and NRD by deciles of Contrast volume / Glomerular filtration rate (calculated using the MDRD equation). The numbers under the solid bars reflect the range of contrast volume/MDRD GFR in each decile. Supplementary Figure 2. Unadjusted and adjusted odds of CIN and NRD by exceeding Contrast volume / glomerular filtration rate (calculated using the MDRD equation) ratio of 2, 2.5 and 3. The adjusted risk of renal complications approaches significance when CV/GFR exceeds 2 and is strongly predictive when the ratio exceeds 3.